<p>Dongyao Pharmaceutical-B (01875.HK) announced its interim results for the six months ending in June, with revenue of 489 million RMB, a year-on-year decrease of 6%. It recorded a net profit of 4.06 million RMB, a decline of 87.1%, with earnings per share of 1 cent. No interim dividend is declared</p>

01875

<p>Dongyao Pharmaceutical - B announced its interim results for the six months ending in June, with revenue of 489 million RMB (the same below), a year-on-year decrease of 6%. It recorded a net profit of 4.06 million RMB, a decline of 87.1%, with earnings per share of 1 cent. No interim dividend is declared</p>

"Performance" Dongyao Pharmaceutical's interim net profit of 4.06 million RMB fell by 87% and no dividend is declared